At University of Utah Health, our urologists have years of experience treating men with enlarged prostate issues — also known as benign prostatic hyperplasia (BPH). When other lines of treatment ...

LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global benign prostatic hyperplasia (BPH) devices market to grow at a CAGR of around 5% during the forecast period, according to their latest ...

The Five-item Frailty Index (5i-FI) is a tool used by physicians to predict surgical risk and postoperative complications after a procedure. Researchers from Brigham and Women's Hospital, a founding ...

(HealthDay News) — Significant change is seen in symptom scores and maximum urinary flow for sham controlled endoscopic and injection benign prostatic hyperplasia interventions, according to a review ...

Benign prostatic hyperplasia (BPH) is an extremely common disease of older men, occurring in more than 70 percent of men over the age of 60. BPH results in substantial morbidity in this patient ...

This manuscript synthesizes findings from a multidisciplinary panel following the RAND/UCLA Appropriateness Method to guide standardization of urinary catheter use after transurethral prostate surgery ...

Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis. Investigators in South Korea demonstrated the benefit in a ...

Benign prostatic hyperplasia (BPH) is a non-cancerous prostate tissue growth affecting men 40 and older. BPH can cause difficulty urinating and may be exacerbated by some cold and allergy medications.

Extracts of the berries of saw palmetto, a small palm tree native to the southeastern U.S., are used widely to treat benign prostatic hyperplasia (BPH). In this randomized trial conducted in ...

A recent study published in the Journal of Internal Medicine investigates the correlations between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and benign prostatic ...